Industries > Pharma > Colon Targeting Drug Delivery Market Report 2020-2030

Colon Targeting Drug Delivery Market Report 2020-2030

Forecasts by Approaches (Primary Approaches and Newly Developed Approaches) and by Polymers (Natural Polymers and Synthetic Polymers). PLUS Profiles Of Leading Companies in Colon Targeting Drug Delivery And Regional And Leading National Market Analysis

PUBLISHED: 14 May 2020
PAGES: 232
PRODUCT CODE: PHA0524

Clear
WOOCS 2.2.1

The colon targeting drug delivery market is estimated to grow at a CAGR of 9.23% over the forecast period.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

The 232-page Visiongain report provides clear detailed insight into the colon targeting drug delivery market. Discover the key trends and development in the market.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global colon targeting drug delivery market forecasts from 2020-2030

• This report also breaks down the revenue forecast to 2030 for the global colon targeting drug delivery market by approaches & polymers type:

• By Approaches:

– Primary Approaches for CDDS
– pH Sensitive Polymer Coated Drug Delivery to the Colon
– Delayed (Time Controlled Release System) Release Drug Delivery to Colon
– Microbially Triggered Drug Delivery to Colon

• Prodrug Approach for Drug Delivery to Colon
• Azo-Polymeric Prodrugs
• Polysaccharide Based Delivery Systems

– Newly Developed Approaches for CDDS categorized into:
– Pressure Controlled Drug-Delivery Systems
– Novel Colon Targeted Delivery System (CODESTM)
– Osmotic Controlled Drug Delivery (ORDS-CT)
– Others

• By Polymers:

– Natural Polymers
– Pectin
– Guar gum
– Dextran
– Chitosan
– Amylose
– Chondroitin Sulfate
– Inulin
– Cyclodextrin
– Locust bean gum
– Others

– Synthetic Polymers

This report discusses the market trends and developments of each submarket.

Colon Targeting Drug Delivery Market Report 2020-2030

• Our study discusses the selected leading companies that are the major players in the colon targeting drug delivery market:
• Baxter International Inc.
• 3M Health Care
• Bayer AG
• Boston Scientific Corporation
• F. Hoffmann-La Roche AG
• GlaxoSmithKline PLC
• Johnson and Johnson
• Novartis AG
• Sanofi SA
• Bausch Health

Visiongain’s study is intended for anyone requiring commercial analyses for the global colon targeting drug delivery market. You find data, trends and predictions.

Buy our report today Colon Targeting Drug Delivery Market Report 2020-2030: Forecasts by Approaches (Primary Approaches and Newly Developed Approaches) and by Polymers (Natural Polymers and Synthetic Polymers). PLUS Profiles Of Leading Companies And Regional And Leading National Market Analysis. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Colon Targeting Drug Delivery Market Report 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Colon Targeting Drug Delivery Market Report 2020-2030


Latest Pharma news

Visiongain Publishes Biological API Manufacturing Services Market Report 2021-2031

Demand in the early years of the forecast period will come from multinational biotech looking to sign deals with Indian companies and take advantage of the cheaper costs of production for the emerging market.

08 January 2021

READ

Visiongain Publishes Anaesthesia & Respiratory Devices Market Report 2020-2030

The growth can be attributed to the rising prevalence of respiratory diseases, growing awareness for respiratory diseases, and innovations in respiratory and anesthesia devices. However, unfavourable reimbursement policies and lack of patient adherence in respiratory diseases are some of the factors restraining the growth of the anesthesia and respiratory devices market.

07 January 2021

READ

Visiongain Publishes Inactivated Vaccines Market Report 2020-2030

Factors such as rise in the prevalence of the infectious and bacterial diseases and active participation of government in vaccine development are driving the growth of this market. While high cost of vaccine development is the key factor emerging as a growth barrier over years in this market.

07 January 2021

READ

Visiongain Publishes Human Microbiome Therapeutics Market Report 2021-2031

The potential of microbiome-based drugs as novel treatments to address the unmet needs for many diseases has contributed intensively to the rapid emergence of many investors in this area. Currently, no regulatory framework exists and no drugs have received FDA approval. However, there are several preclinical and clinical-stage companies working with various approaches to develop microbiome-based therapies.

06 January 2021

READ

Categories

Category